PRGO : Summary for Perrigo Company plc Ordinary Sh - Yahoo Finance

U.S. Markets open in 2 hrs 51 mins

Perrigo Company plc (PRGO)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
68.43+0.29 (+0.43%)
At close: 4:02PM EDT

68.00 -0.43 (-0.63%)
Pre-Market: 6:04AM EDT

People also watch
MYLENDPALXNTEVAREGN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close68.14
Open68.06
Bid0.00 x
Ask0.00 x
Day's Range67.36 - 68.75
52 Week Range67.08 - 133.53
Volume1,155,708
Avg. Volume2,051,298
Market Cap9.81B
Beta0.60
PE Ratio (TTM)-6.79
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.64 (0.94%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • The Wall Street Journal3 days ago

    Moody's: Perrigo Filing Delay a "Credit Negative"

    Perrigo Co.’s credit outlook could come under pressure as the pharmaceutical company delays filing its 10-K annual report, according to Moody’s Investors Service.

  • Moody's3 days ago

    Perrigo Company plc -- Moody's: Perrigo's delayed 10-K filing is credit negative

    Announcement: Moody's: Perrigo's delayed 10- K filing is credit negative. Global Credit Research- 20 Mar 2017. New York, March 20, 2017-- Moody's Investors Service commented that On Thursday, March 16, ...

  • Perrigo Provides Update On 2016 Form 10-K Filing
    PR Newswire7 days ago

    Perrigo Provides Update On 2016 Form 10-K Filing

    Perrigo and E&Y have not been able to fully complete their respective reviews of the historical revenue recognition practices associated with the Tysabri® royalty stream by the Form 10-K filing due date under the extension provided by Rule 12b-25 of the Securities Exchange Act of 1934. Any effects related to the final conclusion of these technical accounting matters are not expected to have a material impact on the Company's historical cash flow or future net cash flow. The Company continues to expect to close the sale of the Tysabri® royalty stream to RPI Finance Trust, an affiliate of Royalty Pharma, within the next ten days.